Deciphera Pharmaceuticals (DCPH) ROE US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
ROE, % | ? | -35.0% | -49.0% | -97.4% | -52.4% | -55.6% | -60.2% | ||
Changes by years, y/y, % | +1pp | -14pp | -48pp | +45pp | -3pp | +9.3% |
Deciphera Pharmaceuticals. ROE, %
Deciphera Pharmaceuticals. ROE, changes, pp
Deciphera Pharmaceuticals (DCPH) ROE US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
ROE, % | ? | -40.1% | -45.4% | -50.7% | -55.6% | -60.2% | -60.2% | |
Changes by years, y/y, % | +65pp | +18pp | +7pp | -5pp | -20pp | |||
Changes by quarters, q/q, % | +11pp | -5pp | -5pp | -5pp | -5pp |